cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy
Yige Huang, Li Fan, Man Ying Wong, Zhuofan Lei, Balaji Krishnamachary, Daphne Zhu, Mika P. Cadiz, Ravi Kumar Nagiri, Pearly Ye, Kendra Norman, Maitreyee Bhagwat, Young Jae Lee, H LI, Jingjie Zhu, Sadaf Amin, , Li Gan
This study identifies cGAS-mediated IFN-I signaling as a driver of disease progression in drug-refractory epilepsy, showing that targeting cGAS reduces epileptic phenotypes and inflammation.
bioRxiv · Feb 2, 2026 · PreprintNeuroscience